Novartis Shares Fall 9% After Setbacks in Three Drug Trials
Shares of the Swiss pharmaceutical company dropped sharply on Tuesday after disappointing results from its del-desiran drug trial, according to a CNBC report.
Shares of Novartis fell about 9% on Tuesday after the pharmaceutical company reported setbacks in three drug trials, CNBC reported.
According to the report, investors were particularly disappointed by results from a trial of del-desiran, one of the drugs affected by the setbacks.
The report did not specify further details about the other two trials or the company's response to the results.
Novartis has not issued a public statement addressing the trial outcomes as of the report's publication, according to CNBC.
Sources
- Pharma major Novartis falls 9% after three drug trial setbacks — CNBC — Top News
EGazette summarizes reporting from multiple sources; follow the links for the originals.
Related articles
Global Stock Markets Face Mounting Pressure From AI Slowdown, Middle East Tensions, and Bond Yields
Financial markets show signs of renewed turmoil as geopolitical conflict, AI investment concerns, and rising government bond yields create headwinds for equities.
Dangote Refinery's $1.6 Billion Share Offer Seen as Out of Reach for Many Nigerians
Africa's richest man, Aliko Dangote, is seeking $1.6 billion from investors to fund a major expansion of his oil refinery, but analysts say the offer may be unaffordable for ordinary Nigerians.
Venezuela's PDVSA Signs Energy Cooperation Deal with TotalEnergies Subsidiary
Acting President Delcy Rodriguez oversaw the signing of an agreement between state oil company PDVSA and TotalEnergies E&P New Ventures in Caracas, according to Anadolu Agency.
Fair Featuring Veteran-Owned Businesses and Craft Producers Held at Carpathian Economic Forum
Event brought together local artisans and businesses run by veterans as part of a wider regional economic gathering
Chiltern Railways becomes sixth train operator to enter UK public ownership
The London Marylebone-to-Birmingham operator is the latest to be nationalised as Labour presses ahead with plans to bring all major passenger rail services under public control by the end of 2027.
Senegal: Sadio Mané launches construction of mango agro-industrial park in Casamance
The Senegalese international footballer laid the foundation stone for a mango processing facility, named SM10 Agro, presented as a project aimed at supporting economic development in his native region.
Comments
Loading comments…